Online Order Get In Touch

What are you looking for?

π-Icosa AAV Serotype Screening Platform

  • With its proprietary π-Icosa High-capacity and High-precision AAV serotype screening platform PackGene aims to identify tissue-specific and maximally infective AAV serotypes for clinical trial development. High infectivity and tissue specificity can ultimately reduce the dosage and production cost of AAV-based gene therapies while simultaneously increasing safety and efficacy

AAV Manufacturing Facility
Contact Us

Key Advantages

  • Capacity

    Our platform design results in higher library capacity

  • Precision

    Higher precision AAV-serotype screening

  • Efficacy

    High infectivity and tissue specificity can result in reduced dosage requirements that increase both safety and efficacy.

Intellectual Property

  • PackGene has three patents pending.

    image-scaled-1

    Library＞1 billion mutants
    Screens AAVs for tissue specificity.

Contact Us

Download